These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12683417)

  • 21. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
    Lee ES; Jin SY; Kang BK; Jung YT
    J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
    Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
    Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
    Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus.
    Sørensen KD; Sørensen AB; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
    Virology; 2005 Apr; 334(2):234-44. PubMed ID: 15780873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF
    Dev Biol (Basel); 2001; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses.
    Rasmussen S; Pedersen FS
    Virology; 2004 Nov; 329(2):440-53. PubMed ID: 15518822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SiRNAs do not induce RNA-dependent transcriptional silencing of retrovirus in human cells.
    Haraguchi T; Mizutani T; Yamamichi N; Ito T; Minoguchi S; Iba H
    FEBS Lett; 2007 Oct; 581(25):4949-54. PubMed ID: 17904125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.
    Metzl C; Mischek D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2006 Jul; 80(14):7070-8. PubMed ID: 16809312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
    Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
    J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent and specific inhibition of retrovirus production by coexpression of multiple siRNAs directed against different regions of viral genomes.
    Ye K; Jin S
    Biotechnol Prog; 2006; 22(1):45-52. PubMed ID: 16454491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
    Fragkos M; Anagnou NP; Tubb J; Emery DW
    Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.
    Barsov EV; Hughes SH
    J Virol; 1996 Jun; 70(6):3922-9. PubMed ID: 8648729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
    Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
    Gene; 2006 May; 372():153-61. PubMed ID: 16488559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG; Krisky DM; Ataai MM; Glorioso JC
    Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human polyomavirus JCV late leader peptide region contains important regulatory elements.
    Akan I; Sariyer IK; Biffi R; Palermo V; Woolridge S; White MK; Amini S; Khalili K; Safak M
    Virology; 2006 May; 349(1):66-78. PubMed ID: 16497349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro testing of a potential retroviral vector for producing transgenic livestock.
    Squire KR; Embretson JE; First NL
    Am J Vet Res; 1989 Aug; 50(8):1423-7. PubMed ID: 2551203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.